Literature DB >> 32353464

Mitochondria focused neurotherapeutics for spinal cord injury.

Alexander G Rabchevsky1, Felicia M Michael2, Samir P Patel3.   

Abstract

The mitochondrion is a double membrane structured organelle involved in a variety of regulatory functions such as calcium signaling, production of adenosine triphosphate, apoptosis, reactive oxygen species generation, cell growth, and cell cycling. Impaired mitochondrial function is evident in various neurological disorders stemming from both acute and chronic neural injury. Herein, we review the role of mitochondrial regulation in maintaining cellular homeostasis, the consequences of their dysfunction in relation to pathophysiology after neurotrauma, approaches being used to promote their bioenergetic integrity for neuroprotection, and multifaceted methods being used to preserve/rescue their function following both traumatic brain and spinal cord injury.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32353464      PMCID: PMC9164988          DOI: 10.1016/j.expneurol.2020.113332

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.620


  170 in total

Review 1.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.

Authors:  F Q Schafer; G R Buettner
Journal:  Free Radic Biol Med       Date:  2001-06-01       Impact factor: 7.376

2.  The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.

Authors:  Aurélien Olichon; Laurent J Emorine; Eric Descoins; Laetitia Pelloquin; Laetitia Brichese; Nicole Gas; Emmanuelle Guillou; Cécile Delettre; Annie Valette; Christian P Hamel; Bernard Ducommun; Guy Lenaers; Pascale Belenguer
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

3.  Methylprednisolone in the management of acute spinal cord injuries.

Authors:  M B Bracken
Journal:  Med J Aust       Date:  1990-09-17       Impact factor: 7.738

4.  A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells.

Authors:  Tulin Otamis Price; Fikriye Uras; William A Banks; Nuran Ercal
Journal:  Exp Neurol       Date:  2006-06-05       Impact factor: 5.330

Review 5.  Mitochondrial medicine: pharmacological targeting of mitochondria in disease.

Authors:  J S Armstrong
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

6.  Acquired inhibition of microRNA-124 protects against spinal cord ischemia-reperfusion injury partially through a mitophagy-dependent pathway.

Authors:  Kun Liu; Lihui Yan; Xiaojing Jiang; Yang Yu; Hongbo Liu; Tianxiang Gu; Enyi Shi
Journal:  J Thorac Cardiovasc Surg       Date:  2017-05-23       Impact factor: 5.209

7.  Effects of Mitochondrial Transplantation on Bioenergetics, Cellular Incorporation, and Functional Recovery after Spinal Cord Injury.

Authors:  Jenna L Gollihue; Samir P Patel; Khalid C Eldahan; David H Cox; Renee R Donahue; Bradley K Taylor; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  J Neurotrauma       Date:  2018-04-30       Impact factor: 5.269

8.  The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis.

Authors:  R M Kluck; E Bossy-Wetzel; D R Green; D D Newmeyer
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

9.  The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells.

Authors:  Daniel Tondera; Frank Czauderna; Katharina Paulick; Rolf Schwarzer; Jörg Kaufmann; Ansgar Santel
Journal:  J Cell Sci       Date:  2005-06-28       Impact factor: 5.285

10.  Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.

Authors:  H Zou; W J Henzel; X Liu; A Lutschg; X Wang
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

View more
  7 in total

Review 1.  [Advances of the role of mitochondrial dysfunction in the spinal cord injury and its relevant treatments].

Authors:  Xin Miao; Junqing Lin; Xianyou Zheng
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-07-15

2.  Neuroprotective Effects of Curcumin against Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury in Cultured Primary Rat Astrocyte by Improving Mitochondrial Function and Regulating the ERK Signaling Pathway.

Authors:  Haojie Chen; Guoke Tang; Jiangming Yu; Ronghua Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-12       Impact factor: 2.650

3.  Erodible thermogelling hydrogels for localized mitochondrial transplantation to the spinal cord.

Authors:  Samir P Patel; Felicia M Michael; M Arif Khan; Brian Duggan; Sam Wyse; Daniel R Darby; Krishnaroop Chaudhuri; Jonathan T Pham; Jenna Gollihue; Jason E DeRouchey; Patrick G Sullivan; Tom D Dziubla; Alexander G Rabchevsky
Journal:  Mitochondrion       Date:  2022-04-06       Impact factor: 4.534

4.  Are mitochondria the key to reduce the age-dependent decline in axon growth after spinal cord injury?

Authors:  Theresa C Sutherland; Cédric G Geoffroy
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

5.  Elevated Mitochondrial Reactive Oxygen Species within Cerebrospinal Fluid as New Index in the Early Detection of Lumbar Spinal Stenosis.

Authors:  Jin Young Hong; Hyunseong Kim; Wan-Jin Jeon; Junseon Lee; In-Hyuk Ha
Journal:  Diagnostics (Basel)       Date:  2021-04-22

Review 6.  Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation.

Authors:  Anushruti Ashok; Syed Suhail Andrabi; Saffar Mansoor; Youzhi Kuang; Brian K Kwon; Vinod Labhasetwar
Journal:  Antioxidants (Basel)       Date:  2022-02-17

7.  Photobiomodulation promotes repair following spinal cord injury by restoring neuronal mitochondrial bioenergetics via AMPK/PGC-1α/TFAM pathway.

Authors:  Zhijie Zhu; Xuankang Wang; Zhiwen Song; Xiaoshuang Zuo; Yangguang Ma; Zhihao Zhang; Cheng Ju; Zhuowen Liang; Kun Li; Xueyu Hu; Zhe Wang
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.